Anna-Lena Volckmar
Anna-Lena Volckmar
PostDoc, University Clinic Heidelberg
Verified email at
Cited by
Cited by
A field guide for cancer diagnostics using cell‐free DNA: From principles to practice and clinical applications
AL Volckmar, H Sültmann, A Riediger, T Fioretos, P Schirmacher, ...
Genes, Chromosomes and Cancer 57 (3), 123-139, 2018
Melanocortin-4 receptor in energy homeostasis and obesity pathogenesis
A Hinney, AL Volckmar, N Knoll
Progress in molecular biology and translational science 114, 147-191, 2013
Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians
M Allgäuer, J Budczies, P Christopoulos, V Endris, A Lier, E Rempel, ...
Translational lung cancer research 7 (6), 703, 2018
Size matters: dissecting key parameters for panel‐based tumor mutational burden analysis
I Buchhalter, E Rempel, V Endris, M Allgäuer, O Neumann, AL Volckmar, ...
International journal of cancer 144 (4), 848-858, 2019
Chipping away the ‘missing heritability’: GIANT steps forward in the molecular elucidation of obesity–but still lots to go
J Hebebrand, AL Volckmar, N Knoll, A Hinney
Obesity facts 3 (5), 294-303, 2010
Genome‐wide association study in German patients with attention deficit/hyperactivity disorder
A Hinney, A Scherag, I Jarick, Ö Albayrak, C Pütter, S Pechlivanis, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156 …, 2011
Common obesity risk alleles in childhood attention‐deficit/hyperactivity disorder
Ö Albayrak, C Puetter, AL Volckmar, S Cichon, P Hoffmann, MM Noethen, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 162 …, 2013
Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real‐life analysis of three larger gene panels
V Endris, I Buchhalter, M Allgäuer, E Rempel, A Lier, AL Volckmar, ...
International journal of cancer 144 (9), 2303-2312, 2019
Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder
I Jarick, AL Volckmar, C Pütter, S Pechlivanis, TT Nguyen, ...
Molecular psychiatry 19 (1), 115-121, 2014
Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: analysis of the first 3,000 Heidelberg cases
AL Volckmar, J Leichsenring, M Kirchner, P Christopoulos, O Neumann, ...
International Journal of Cancer 145 (3), 649-661, 2019
Variant classification in precision oncology
J Leichsenring, P Horak, S Kreutzfeldt, C Heining, P Christopoulos, ...
International journal of cancer 145 (11), 2996-3010, 2019
Molecular genetic aspects of weight regulation
J Hebebrand, A Hinney, N Knoll, AL Volckmar, A Scherag
Deutsches Aerzteblatt International 110 (19), 338, 2013
Genetics of eating disorders
A Hinney, AL Volckmar
Current psychiatry reports 15, 1-9, 2013
Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index
A Hinney, M Kesselmeier, S Jall, AL Volckmar, M Föcker, J Antel, IM Heid, ...
Molecular psychiatry 22 (2), 192-201, 2017
Spatial and temporal heterogeneity of panel-based tumor mutational burden in pulmonary adenocarcinoma: separating biology from technical artifacts
D Kazdal, V Endris, M Allgäuer, M Kriegsmann, J Leichsenring, ...
Journal of Thoracic Oncology 14 (11), 1935-1947, 2019
Investigation of a genome wide association signal for obesity: synthetic association and haplotype analyses at the melanocortin 4 receptor gene locus
A Scherag, I Jarick, J Grothe, H Biebermann, S Scherag, AL Volckmar, ...
PloS one 5 (11), e13967, 2010
Pathway analysis in attention deficit hyperactivity disorder: an ensemble approach
MA Mooney, SK McWeeney, SV Faraone, A Hinney, J Hebebrand, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 171 …, 2016
Decreased melanocortin‐4 receptor function conferred by an infrequent variant at the human melanocortin receptor accessory protein 2 gene
L Schonnop, G Kleinau, N Herrfurth, AL Volckmar, C Cetindag, A Müller, ...
Obesity 24 (9), 1976-1982, 2016
Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy
C Menzer, B Beedgen, J Rom, CM Duffert, AL Volckmar, O Sedlaczek, ...
European journal of cancer 104, 239-242, 2018
The BRCA2 mutation status shapes the immune phenotype of prostate cancer
M Jenzer, P Keß, C Nientiedt, V Endris, M Kippenberger, J Leichsenring, ...
Cancer Immunology, Immunotherapy 68, 1621-1633, 2019
The system can't perform the operation now. Try again later.
Articles 1–20